Sinphar Pharmaceutical Co Ltd (1734) — Capital Reinvestment Ratio
Sinphar Pharmaceutical Co Ltd (1734) has a Capital Reinvestment Ratio of 0.34x as of December 2025, meaning it reinvests 0% of its operating cash flow (NT$200.63 Million) in capital expenditures (NT$67.64 Million). See Sinphar Pharmaceutical Co Ltd balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sinphar Pharmaceutical Co Ltd Capital Reinvestment Ratio (2003–2025)
This chart tracks Sinphar Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 22 annual periods. Check cash flow reinvestment rate of Sinphar Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sinphar Pharmaceutical Co Ltd (2003–2025)
Year-by-year Capital Reinvestment Ratio for Sinphar Pharmaceutical Co Ltd from 2003 to 2025. For live market cap and broader valuation context, see how much is Sinphar Pharmaceutical Co Ltd worth.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | NT$584.66 Million | NT$200.94 Million | ▼ -20.5% |
| 2024 | 0.43x | NT$593.51 Million | NT$256.71 Million | ▼ -57.4% |
| 2023 | 1.02x | NT$296.37 Million | NT$300.94 Million | ▲ +181.4% |
| 2022 | 0.36x | NT$425.30 Million | NT$153.44 Million | ▼ -69.7% |
| 2021 | 1.19x | NT$135.54 Million | NT$161.44 Million | ▲ +10.5% |
| 2020 | 1.08x | NT$146.39 Million | NT$157.77 Million | ▼ -66.5% |
| 2018 | 3.22x | NT$79.50 Million | NT$255.69 Million | ▲ +313.5% |
| 2017 | 0.78x | NT$219.87 Million | NT$171.00 Million | ▼ -69.8% |
| 2016 | 2.58x | NT$87.18 Million | NT$224.85 Million | ▲ +75.6% |
| 2015 | 1.47x | NT$280.53 Million | NT$412.04 Million | ▼ -25.8% |
| 2014 | 1.98x | NT$148.58 Million | NT$294.29 Million | ▼ -1.6% |
| 2013 | 2.01x | NT$297.09 Million | NT$598.16 Million | ▼ -11.8% |
| 2012 | 2.28x | NT$164.45 Million | NT$375.19 Million | ▲ +42.3% |
| 2011 | 1.60x | NT$225.58 Million | NT$361.69 Million | ▲ +43.2% |
| 2010 | 1.12x | NT$261.49 Million | NT$292.75 Million | ▲ +57.9% |
| 2009 | 0.71x | NT$309.94 Million | NT$219.71 Million | ▼ -17.6% |
| 2008 | 0.86x | NT$271.01 Million | NT$233.25 Million | ▼ -63.7% |
| 2007 | 2.37x | NT$174.85 Million | NT$414.90 Million | ▲ +58.5% |
| 2006 | 1.50x | NT$166.57 Million | NT$249.44 Million | ▼ -3.1% |
| 2005 | 1.55x | NT$122.09 Million | NT$188.76 Million | ▲ +68.1% |
| 2004 | 0.92x | NT$174.81 Million | NT$160.79 Million | ▼ -57.3% |
| 2003 | 2.16x | NT$120.84 Million | NT$260.50 Million | — |